ERCC1 underexpression
|
Soft Tissue Sarcoma
|
ERCC1 underexpression
|
Soft Tissue Sarcoma
|
cisplatin + pemetrexed Sensitive: C3 – Early Trials
|
cisplatin + pemetrexed Sensitive: C3 – Early Trials
|
ERCC1 underexpression
|
Bladder Cancer
|
ERCC1 underexpression
|
Bladder Cancer
|
cisplatin + gemcitabine Sensitive: C3 – Early Trials
|
cisplatin + gemcitabine Sensitive: C3 – Early Trials
|